TCM Syndrome Differentiation Treatment on Discharged Elderly Patients With CAP
Status:
Not yet recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
This study is to evaluate the efficacy and safety of TCM syndrome differentiation treatment
on the rehospitalization rate of discharged elderly patients with community acquired
pneumonia(CAP)and to explore its mechanism.